Search

1 to 10 of 21
Sort by

Library Entry
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article in which data shows that modulation of the tumor immune microenvironment with CTX/L-NIL enhances susceptibility of treatment-refractory tumors to CRT. Authors: Aurelie Hanoteau, Jared M. Newton , Rosemarie...



Library Entry
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article which reports pre-clinical data showing that combination immunotherapy with CD73 blockade and CAR-NK-92 cells shows improved anti-cancer effects against CD73 + solid tumor targets both in vitro and in vivo. ...


Library Entry
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article which examined if olaparib, when combined with IgG 1 antibody-dependent cellular cytotoxicity (ADCC)-mediating monoclonal antibodies (mAbs) cetuximab (anti-EGFR), or avelumab (anti-PD-L1), would increase tumor...


Library Entry
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article about open-label, first-in-human, phase 1 study evaluated the safety, pharmacokinetics, pharmacodynamics, and maximum tolerated dose (MTD) of AMG 228, an agonistic human IgG1 monoclonal antibody targeting...


Library Entry
Living with Melanoma Symposium: Complications of Immunotherapy

Presentation given by Ragini Kudchadkar, MD, as part of the AIM at Melanoma’s Living With Melanoma - Symposium on September 23, 2017 at Winship Cancer institute at Emory University. #Melanoma #Video #CollaborativePartner #SideEffects #AdverseEvents #Biomarkers ...


Library Entry
Understanding Melanoma: Treatment Options - Immunotherapy

From AIM at Melanoma, this article describes the different immunotherapy treatment options approved for the treatment of melanoma. Click here to read "Understanding Melanoma: Treatment Options - Immunotherapy" #Melanoma #WebPage #CollaborativePartner #Immunomodulators ...